Task: Answer the multiple-choice question.
Query: Which drug exhibits a -19.755% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CC#CC(=O)NC1CCCN(C2Cc3ccccc3C2)C1
b. CCN(CC)CC1C(=O)N(c2ccc(OC)cc2)C1c1ccccc1
Answer: b. CCN(CC)CC1C(=O)N(c2ccc(OC)cc2)C1c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)CC1C(=O)N(c2ccc(OC)cc2)C1c1ccccc1
CCN(CC)CC1C(=O)N(c2ccc(OC)cc2)C1c1ccccc1
3-(diethylaminomethyl)-1-(4-methoxyphenyl)-4-phenylazetidin-2-one